APOB and coronary artery disorder: Arnold et al. published the largest study investigating the impact of Lp(a) level on LDL-C- or apoB-related risk of CHD in a prospective cohort of 68 748 CHD-free individuals followed for a median of 9.7 years for incident CHD events.